News
-
Read about Dr Zalihe (Zal) Hakki, Chemistry, Williams Group, developing drugs against steroid-resistant asthma
-
Read about Qiong Yang (Yang), Research Fellow at the Pest & Environmental Adaptation Research Group (PEARG) at Bio21.
-
Bio21's Isabelle Rouiller, as part of an international team, has used powerful Cryo-EM microscopy to discover how small molecules can be used to ‘open up’ the HIV virus – allowing the immune system to target and destroy it.
-
Asmini Athman is the Lab Manager & OHS Advisor of the MDHS Infrastructure & Facilities team.
-
Read about Fiona Houghton, Dept Biochemistry and Molecular Biology, Bio21, Gleeson Lab
-
A new drug delays motor neurone disease progression and improves cognitive and clinical symptoms according to recently announced trial results.
-
Congratulations to Bio21's Danny Hatters, Jose Villadangos, Malcolm McConville, Justine Mintern, Stuart Ralph, Kat Holt and Paul Gleeson whose research has received NHMRC funding.
-
The University of Melbourne has honoured two if its most revered scientists at the opening of the expanded Bio21 Institute of Molecular Science and Biotechnology on Friday. The state-of-the-art, $46 million research building expands the footprint of the Bio21 Institute by 5000 square metres.
-
The Honourable John Brumby AO today formally opened the new ‘Nancy Millis’ building, an expansion of the Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, incorporating CSL’s Global Hub for Research and Translational Medicine.
-
Michael Parker, Director Bio21 Institute and Rick Pearson, Peter MacCallum Cancer Centre, at the ACRF award ceremony, 28 November.